SGMO | Sangamo Therapeutics
Category: Biotechnology company
Quick infos Headquarters: Richmond, California, United States Trade prices Volume: Market Cap: 1.21B Prev closed: 11.75 Open: 11.75 High: 11.8 Low: 11.2 52 week low: 8.51 52 week high: 19.43 Dividends: No Dividends Next ER: November 4, 2021
About the Company Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.
Earnings History Date EPS / Forecast Revenue / Forecast March 3, 2022 November 4, 2021 -0.33 / -0.336928.56M / 25.96MBeat! August 5, 2021 -0.33 / -0.313127.87M / 26.53MBeat! May 4, 2021 -0.32 / -0.293626.28M / 28.49MFebruary 24, 2021 -0.29 / -0.212725.8M / 31.42Mview more
Historical Data Date Price Open High Low Vol Change ER Nov 26, 2021 8.45 8.67 8.74
8.34
999.78K -5.48% Nov 24, 2021 8.94 8.83 9.02
8.72
1.72M 0.11% Nov 23, 2021 8.93 8.90 8.97
8.60
1.13M 0.11% Nov 22, 2021 8.92 9.10 9.30
8.90
1.19M -1.65% Nov 19, 2021 9.07 9.28 9.35
8.99
1.18M -2.68% Nov 18, 2021 9.32 9.56 9.67
9.27
1.57M -2.1% Nov 17, 2021 9.52 9.71 9.71
9.37
863.24K -2.86% Nov 16, 2021 9.80 9.86 9.89
9.66
642.90K -0.2% Nov 15, 2021 9.82 10.23 10.34
9.78
835.14K -3.25% Nov 12, 2021 10.15 10.13 10.27
9.96
1.05M 1.10% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US8006771062 CUSIP: 800677106 Founded:1995 Employees:131 News
Sangamo Therapeutics (SGMO) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com Jun 16, 2021 5:45 pm
Sangamo Therapeutics, Inc. to Host Earnings Call finance.yahoo.com Jun 16, 2021 3:15 pm
Sangamo Therapeutics, Inc. to Host Earnings Call finance.yahoo.com Jun 16, 2021 3:15 pm
Sangamo Therapeutics, Inc. to Host Earnings Call finance.yahoo.com Jun 16, 2021 3:15 pm
Will Sangamo Therapeutics (SGMO) Report Negative Q3 Earnings? What You Should Know finance.yahoo.com Jun 16, 2021 12:32 pm Sangamo Therapeutics Sees RS Rating Rise To 85 And Composite Rating At 81 investors.com Jun 16, 2021 10:40 am
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy finance.yahoo.com Jun 16, 2021 9:00 am CATB, XELB, CLSD and DTEA among after-hours movers seekingalpha.com Jun 16, 2021 5:40 am 3 Stocks to Buy With Over 50% Upside Potential – The ... wmleader.com Jun 15, 2021 4:07 pm RBC Capital: 3 Stocks to Buy With Over 50% Upside Potential nasdaq.com Jun 15, 2021 4:07 pm
RBC Capital: 3 Stocks to Buy With Over 50% Upside Potential finance.yahoo.com Jun 14, 2021 11:51 am BioMarin: Depressed Price Due To CRL, Major Catalysts Ahead seekingalpha.com Jun 2, 2021 4:07 pm Sangamo's Hemophilia A Treatment: An Assessment seekingalpha.com Jun 2, 2021 4:07 pm Sangamo Therapeutics names Prathyusha Duraibabu as CFO seekingalpha.com May 25, 2021 12:20 pm
Sangamo Therapeutics Appoints Prathyusha Duraibabu, CPA, MBA, to Chief Financial Officer finance.yahoo.com May 24, 2021 4:15 pm We Think Some Shareholders May Hesitate To Increase ... simplywall.st May 16, 2021 4:07 pm
Wasatch Global on Sangamo (SGMO): We Remain Optimistic About its Future Prospects finance.yahoo.com May 12, 2021 1:52 pm Sangamo shares fall after hours as Q1 net loss widens, misses on EPS seekingalpha.com May 5, 2021 5:39 am
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates finance.yahoo.com May 4, 2021 5:25 pm
Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene & Cell Therapy finance.yahoo.com Apr 27, 2021 4:30 pm This company doesn't provide a dividend.
Key Persons CEO : Alexander Macrae, PhD Talk about Sangamo Therapeutics below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: sangamo.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
